Latest News about FDA
Recent news which mentions FDA
No Escape for Big Oil: US Supreme Court Denies Exxon, Chevron's Climate-Change Case Venue Swap
April 24, 2023
From Benzinga
With FDA Submission For Sickle Cell Gene Therapy, Bluebird Bio Can Potentially Have 3 Approved Products By 2023
April 24, 2023
From Benzinga
Applied Therapeutics' Investigational Drug Shows Clinical Benefit In Rare Metabolic Disorder, Chalks Out FDA Submission Plans
April 24, 2023
Tickers
APLT
From Benzinga
More Trouble For Foghorn Therapeutics: After Blood Cancer Trial, FDA Puts Another Cancer Trial On Clinical Hold
April 24, 2023
Tickers
FHTX
From Benzinga
From Benzinga
Psychedelics Reform Update: NC's $5M Grant, WA's Pilot Program, Plus Rescheduling Proposals
April 21, 2023
From Benzinga
Avanos Medical Recalls Certain BALLARD ACCESS Closed Suction Systems For Pediatric Use Citing Ventilation Risk
April 21, 2023
Tickers
AVNS
From Benzinga
EXCLUSIVE: Dr. Johnson Lectures On Psychedelic-Assisted Therapy At Benzinga Capital Conference
April 20, 2023
From Benzinga
DBV Technologies Outlines Regulatory Path For Viaskin Peanut Allergy Patch For Kids Below 3 Years
April 20, 2023
Tickers
DBVT
From Benzinga
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
April 20, 2023
From Benzinga
# 1 Facial Skin Device Brand Spa Sciences Receives FDA Clearance for its IPL Device LEXI for Home-Use Hair Removal
April 19, 2023
Tickers
IPL
From PRLog
FDA Gives Green Signal To Second Omicron-Adapted Booster Shots For People At High Risk From Covid
April 18, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.